Tenmile Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Investment

Participated as an existing investor in AdvanCell's oversubscribed, upsized US$315M Series D led by Ally Bridge Group to advance targeted alpha radiopharmaceutical therapies.

AdvanCell Isotopes

JUL 15, 2026

Investment

Proton Intelligence

DEC 24, 2024

New Fund

Tenmile launch - $250M health technology investment fund

AUG 15, 2022